Westlake targets $450M for Seidenberg and Harper’s next life sciences fund

Life sciences VC firm Westlake Village BioPartners is ready to restock its capital reserves shortly after its success with bringing portfolio company Acelyrin to one of the biggest IPOs in recent biotech memory.

The Los Angeles venture firm — led by well-known ex-Kleiner Perkins investor Beth Seidenberg and former Amgen…
Click here to view original post